// App-Quantinova.ai

5033 : PSA response in black and white patients treated with abiraterone acetate (AA) for metastatic castrate resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Sundhar Ramalingam

Principal Investigators

  • Michael Sandon Humeniuk

  • Rachel Hu

  • Julia Rasmussen

  • Patrick Healy

  • Yuan Wu

  • Michael Roger Harrison

  • Andrew J. Armstrong

  • Daniel J. George

  • Tian Zhang

Medical Centers

  • Duke University Medical Center, Durham, NC

  • Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC

  • Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC

  • Duke Cancer Institute, Durham, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Prostate specific antigen

  • Human albumin

Drug/Treatment

  • Alkaline phosphatase

  • CB-7598

  • Enzalutamide

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved